Stay updated with breaking news from Therapy Manufacturing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MINNEAPOLIS, Jan. 4, 2024 /PRNewswire/ -- Bio-Techne Corporation today announced it will present its portfolio of products and solutions to enable cell and gene therapy development and...
LOS ANGELES--(BUSINESS WIRE)--Sep 26, 2023--
ACTengine® IMA203 TCR-T monotherapy against PRAME showed 50% confirmed objective response rate (cORR) at or above target dose in different solid cancers in an interim clinical update in Phase 1a and Phase
14.03.2023 - - Announced positive clinical data from AQUAx AAV-hAQP1 Phase 1 trial for treatment of Grade 2/3 Radiation-Induced Xerostomia in December 2022 - Announced positive top-line data from the MGT009 Phase 1/2 clinical study demonstrating safety and ...
/PRNewswire/ -- The "Global TIL Therapies Market : Distribution by Target Indication, Key Players and Key Geographical Regions: Industry Trends and Global...